feed,title,long_url,short_url
SeekingAlpha,Buy Rating For ServiceNow Due To Solid Execution In An Uncertain Environment,https://seekingalpha.com/article/4600869,
SeekingAlpha,MiMedx's Post-Q1 2023 Surge Could Result In Profit-Taking,https://seekingalpha.com/article/4600868,
SeekingAlpha,Selling Hikma Pharmaceuticals After A 40% Share Price Gain In 7 Months,https://seekingalpha.com/article/4600867,
